Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study

Christoph Laske, Hamid R. Sohrabi, Mateusz S. Jasielec, Stephan Müller, Niklas K. Koehler, Susanne Gräber, Stefan Förster, Alexander Drzezga, Felix Mueller-Sarnowski, Adrian Danek, Mathias Jucker, Randall J. Bateman, Virginia Buckles, Andrew Saykin, Ralph N. Martins, John C. Morris

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective. We examined the diagnostic value of subjective memory complaints (SMCs) assessed with a single item in a large cross-sectional cohort consisting of families with autosomal dominant Alzheimer's disease (ADAD) participating in the Dominantly Inherited Alzheimer Network (DIAN). Methods. The baseline sample of 183 mutation carriers (MCs) and 117 noncarriers (NCs) was divided according to Clinical Dementia Rating (CDR) scale into preclinical (CDR 0; MCs: n = 107; NCs: n = 109), early symptomatic (CDR 0.5; MCs: n = 48; NCs: n = 8), and dementia stage (CDR ≥ 1; MCs: n = 28; NCs: n = 0). These groups were subdivided by the presence or absence of SMCs. Results. At CDR 0, SMCs were present in 12.1% of MCs and 9.2% of NCs (P = 0.6). At CDR 0.5, SMCs were present in 66.7% of MCs and 62.5% of NCs (P = 1.0). At CDR ≥ 1, SMCs were present in 96.4% of MCs. SMCs in MCs were significantly associated with CDR, logical memory scores, Geriatric Depression Scale, education, and estimated years to onset. Conclusions. The present study shows that SMCs assessed by a single-item scale have no diagnostic value to identify preclinical ADAD in asymptomatic individuals. These results demonstrate the need of further improvement of SMC measures that should be examined in large clinical trials.

Original languageEnglish
Article number828120
JournalBioMed Research International
Volume2015
DOIs
StatePublished - 2015

Fingerprint

Dementia
Alzheimer Disease
Data storage equipment
Mutation
Geriatrics
Education
Clinical Trials
Depression

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease : Results of the DIAN Study. / Laske, Christoph; Sohrabi, Hamid R.; Jasielec, Mateusz S.; Müller, Stephan; Koehler, Niklas K.; Gräber, Susanne; Förster, Stefan; Drzezga, Alexander; Mueller-Sarnowski, Felix; Danek, Adrian; Jucker, Mathias; Bateman, Randall J.; Buckles, Virginia; Saykin, Andrew; Martins, Ralph N.; Morris, John C.

In: BioMed Research International, Vol. 2015, 828120, 2015.

Research output: Contribution to journalArticle

Laske, C, Sohrabi, HR, Jasielec, MS, Müller, S, Koehler, NK, Gräber, S, Förster, S, Drzezga, A, Mueller-Sarnowski, F, Danek, A, Jucker, M, Bateman, RJ, Buckles, V, Saykin, A, Martins, RN & Morris, JC 2015, 'Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study', BioMed Research International, vol. 2015, 828120. https://doi.org/10.1155/2015/828120
Laske, Christoph ; Sohrabi, Hamid R. ; Jasielec, Mateusz S. ; Müller, Stephan ; Koehler, Niklas K. ; Gräber, Susanne ; Förster, Stefan ; Drzezga, Alexander ; Mueller-Sarnowski, Felix ; Danek, Adrian ; Jucker, Mathias ; Bateman, Randall J. ; Buckles, Virginia ; Saykin, Andrew ; Martins, Ralph N. ; Morris, John C. / Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease : Results of the DIAN Study. In: BioMed Research International. 2015 ; Vol. 2015.
@article{bbb5bb411c584b5fb3a30ccbf9012ecc,
title = "Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease: Results of the DIAN Study",
abstract = "Objective. We examined the diagnostic value of subjective memory complaints (SMCs) assessed with a single item in a large cross-sectional cohort consisting of families with autosomal dominant Alzheimer's disease (ADAD) participating in the Dominantly Inherited Alzheimer Network (DIAN). Methods. The baseline sample of 183 mutation carriers (MCs) and 117 noncarriers (NCs) was divided according to Clinical Dementia Rating (CDR) scale into preclinical (CDR 0; MCs: n = 107; NCs: n = 109), early symptomatic (CDR 0.5; MCs: n = 48; NCs: n = 8), and dementia stage (CDR ≥ 1; MCs: n = 28; NCs: n = 0). These groups were subdivided by the presence or absence of SMCs. Results. At CDR 0, SMCs were present in 12.1{\%} of MCs and 9.2{\%} of NCs (P = 0.6). At CDR 0.5, SMCs were present in 66.7{\%} of MCs and 62.5{\%} of NCs (P = 1.0). At CDR ≥ 1, SMCs were present in 96.4{\%} of MCs. SMCs in MCs were significantly associated with CDR, logical memory scores, Geriatric Depression Scale, education, and estimated years to onset. Conclusions. The present study shows that SMCs assessed by a single-item scale have no diagnostic value to identify preclinical ADAD in asymptomatic individuals. These results demonstrate the need of further improvement of SMC measures that should be examined in large clinical trials.",
author = "Christoph Laske and Sohrabi, {Hamid R.} and Jasielec, {Mateusz S.} and Stephan M{\"u}ller and Koehler, {Niklas K.} and Susanne Gr{\"a}ber and Stefan F{\"o}rster and Alexander Drzezga and Felix Mueller-Sarnowski and Adrian Danek and Mathias Jucker and Bateman, {Randall J.} and Virginia Buckles and Andrew Saykin and Martins, {Ralph N.} and Morris, {John C.}",
year = "2015",
doi = "10.1155/2015/828120",
language = "English",
volume = "2015",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Diagnostic Value of Subjective Memory Complaints Assessed with a Single Item in Dominantly Inherited Alzheimer's Disease

T2 - Results of the DIAN Study

AU - Laske, Christoph

AU - Sohrabi, Hamid R.

AU - Jasielec, Mateusz S.

AU - Müller, Stephan

AU - Koehler, Niklas K.

AU - Gräber, Susanne

AU - Förster, Stefan

AU - Drzezga, Alexander

AU - Mueller-Sarnowski, Felix

AU - Danek, Adrian

AU - Jucker, Mathias

AU - Bateman, Randall J.

AU - Buckles, Virginia

AU - Saykin, Andrew

AU - Martins, Ralph N.

AU - Morris, John C.

PY - 2015

Y1 - 2015

N2 - Objective. We examined the diagnostic value of subjective memory complaints (SMCs) assessed with a single item in a large cross-sectional cohort consisting of families with autosomal dominant Alzheimer's disease (ADAD) participating in the Dominantly Inherited Alzheimer Network (DIAN). Methods. The baseline sample of 183 mutation carriers (MCs) and 117 noncarriers (NCs) was divided according to Clinical Dementia Rating (CDR) scale into preclinical (CDR 0; MCs: n = 107; NCs: n = 109), early symptomatic (CDR 0.5; MCs: n = 48; NCs: n = 8), and dementia stage (CDR ≥ 1; MCs: n = 28; NCs: n = 0). These groups were subdivided by the presence or absence of SMCs. Results. At CDR 0, SMCs were present in 12.1% of MCs and 9.2% of NCs (P = 0.6). At CDR 0.5, SMCs were present in 66.7% of MCs and 62.5% of NCs (P = 1.0). At CDR ≥ 1, SMCs were present in 96.4% of MCs. SMCs in MCs were significantly associated with CDR, logical memory scores, Geriatric Depression Scale, education, and estimated years to onset. Conclusions. The present study shows that SMCs assessed by a single-item scale have no diagnostic value to identify preclinical ADAD in asymptomatic individuals. These results demonstrate the need of further improvement of SMC measures that should be examined in large clinical trials.

AB - Objective. We examined the diagnostic value of subjective memory complaints (SMCs) assessed with a single item in a large cross-sectional cohort consisting of families with autosomal dominant Alzheimer's disease (ADAD) participating in the Dominantly Inherited Alzheimer Network (DIAN). Methods. The baseline sample of 183 mutation carriers (MCs) and 117 noncarriers (NCs) was divided according to Clinical Dementia Rating (CDR) scale into preclinical (CDR 0; MCs: n = 107; NCs: n = 109), early symptomatic (CDR 0.5; MCs: n = 48; NCs: n = 8), and dementia stage (CDR ≥ 1; MCs: n = 28; NCs: n = 0). These groups were subdivided by the presence or absence of SMCs. Results. At CDR 0, SMCs were present in 12.1% of MCs and 9.2% of NCs (P = 0.6). At CDR 0.5, SMCs were present in 66.7% of MCs and 62.5% of NCs (P = 1.0). At CDR ≥ 1, SMCs were present in 96.4% of MCs. SMCs in MCs were significantly associated with CDR, logical memory scores, Geriatric Depression Scale, education, and estimated years to onset. Conclusions. The present study shows that SMCs assessed by a single-item scale have no diagnostic value to identify preclinical ADAD in asymptomatic individuals. These results demonstrate the need of further improvement of SMC measures that should be examined in large clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84928128339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928128339&partnerID=8YFLogxK

U2 - 10.1155/2015/828120

DO - 10.1155/2015/828120

M3 - Article

C2 - 25922840

AN - SCOPUS:84928128339

VL - 2015

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 828120

ER -